About the Kelly Group

---

I started the Kelly Group in the fall of 2018 after retiring from SoBran Inc.  At SoBran I was responsible for all of the company's operations and business development. I lead a team of over 700 clinicians, scientists and technicians that provided pre-clinical safety and efficacy studies, laboratory animal care and  CBRNE agent detection for institutional clients. My clients included multiple agencies of the Federal government, academic institutions across the country, pharmaceutical firms and biotech startups.

My goal is to use my decades of experience leading large complex research support efforts to help small and mid-sized biotech and biopharma firms succeed. As a consultant I will help them succeed by supplementing their own expertise with my own or by tapping my network of subject matter experts to find my clients the resources and expertise they need.

Over the years I’ve accumulated a wealth of experience in a range of disciplines focused on molecular biology and toxicology that I'm anxious to share. My interests center around improving laboratory and business operations, pre-clinical study support, regulatory affairs and research compliance.  Here is a link to my resume.